Literature DB >> 2970226

Phenylarsine oxide and denervation effects on hormone-stimulated glucose transport.

M O Sowell1, K A Robinson, M G Buse.   

Abstract

Insulin and insulin-like growth factor I (IGF-I) stimulate glucose transport in skeletal muscle through separate receptors. The proximal postreceptor events in coupling insulin and IGF-I receptors to glucose transport have been suggested to differ. Denervation of skeletal muscle produces a postreceptor insulin resistance presumably at an early step in the signaling cascade. We examined the effects of denervation and phenylarsine oxide (PAO), an agent believed to block insulin action on transport at a postreceptor step, on insulin and IGF-I stimulated 2-deoxy-D-glucose transport in isolated solei. Denervation (24 h) produced severe IGF-I resistance without affecting IGF-I receptor number or affinity. PAO inhibited insulin and IGF-I stimulation of transport in control muscles by approximately 90 and approximately 70%, respectively. In denervated muscle PAO inhibited transport stimulation by both hormones less than in controls. Conclusions are that 1) skeletal muscle insulin and IGF-I receptors signal transport mainly through a PAO-sensitive mechanism, but IGF-I's action involves a larger PAO-resistant component; 2) the denervation-induced postreceptor resistance of glucose transport to both hormones involves primarily the PAO-sensitive pathway.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970226     DOI: 10.1152/ajpendo.1988.255.2.E159

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  In vivo stimulation of the insulin receptor kinase in human skeletal muscle. Correlation with insulin-stimulated glucose disposal during euglycemic clamp studies.

Authors:  G R Freidenberg; S L Suter; R R Henry; D Reichart; J M Olefsky
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

2.  Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes.

Authors:  David S Paul; Araceli Hernández-Zavala; Felecia S Walton; Blakely M Adair; Jirí Dedina; Tomás Matousek; Miroslav Stýblo
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-30       Impact factor: 4.219

Review 3.  Preclinical rodent models of physical inactivity-induced muscle insulin resistance: challenges and solutions.

Authors:  Paul T Reidy; Jackie M Monnig; Carrie E Pickering; Katsuhiko Funai; Micah J Drummond
Journal:  J Appl Physiol (1985)       Date:  2020-12-24

4.  Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid.

Authors:  David S Paul; Anne W Harmon; Vicenta Devesa; David J Thomas; Miroslav Stýblo
Journal:  Environ Health Perspect       Date:  2007-01-29       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.